These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6834245)

  • 1. Nonlinear pharmacokinetics of the new positive inotropic agent sulmazole in the dog.
    Garrett ER; Roth W
    J Pharm Sci; 1983 Feb; 72(2):105-16. PubMed ID: 6834245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The response of the calcium dependent myocardial contractility to the new cardiotonic agent sulmazole.
    Achenbach C; Ziskoven R; Wiemer J; Hauswirth O
    Arzneimittelforschung; 1984; 34(11):1498-506. PubMed ID: 6543125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of arylimidazopyridine cardiotonics: discovery and inotropic activity of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine.
    Robertson DW; Beedle EE; Krushinski JH; Pollock GD; Wilson H; Wyss VL; Hayes JS
    J Med Chem; 1985 Jun; 28(6):717-27. PubMed ID: 4009593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the new cardiotonic agent sulmazole on the slow inward current of sheep cardiac Purkinje fibres.
    Achenbach C; Ziskoven R; Wiemer J; Hauswirth O
    Arzneimittelforschung; 1984; 34(12):1743-9. PubMed ID: 6099128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulmazole effects on mechanical performance of hypoxic and reoxygenated isolated mammalian myocardium.
    Bonoron-Adèle S; Grellet J; Bricaud H; Tariosse L; Besse P
    Arzneimittelforschung; 1986 Nov; 36(11):1572-7. PubMed ID: 3814219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic activity of different doses of sulmazole by infusion.
    Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
    Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the cardiovascular and biochemical actions of the imidazo [4,5b] pyridine sulmazole and an imidazo [4,5c] pyridine analogue, BW A746C.
    Allan G; Cambridge D; Follenfant MJ; Stone D; Whiting MV
    Br J Pharmacol; 1988 Feb; 93(2):387-98. PubMed ID: 3359112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid, sensitive and fully automated high-performance liquid chromatographic assay with fluorescence detection for sulmazole and metabolites.
    Roth W
    J Chromatogr; 1983 Dec; 278(2):347-57. PubMed ID: 6668315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and pharmacokinetics of the cardiotonic agent piroximone and of its major metabolite in dog.
    Berg-Candolfi M; Dulery B; Jehl F; Haegele KD
    Xenobiotica; 1995 Jan; 25(1):59-70. PubMed ID: 7604607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidazopyridines: roles of pyridine nitrogen position and methylsulfinyl oxygen for in vitro positive inotropic mechanism and chronotropic activity.
    Honerjäger P; Klockow M; Schönsteiner G; Jonas R
    J Cardiovasc Pharmacol; 1989 May; 13(5):673-81. PubMed ID: 2472514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of AR-L 115 BS in the rat (author's transl)].
    Busch U
    Arzneimittelforschung; 1981; 31(1a):204-9. PubMed ID: 7195222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of AR-L 115 BS in rhesus monkeys (author's transl)].
    Mierau J
    Arzneimittelforschung; 1981; 31(1a):221-5. PubMed ID: 7195226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of AR-L 115 BS in rabbits and dogs].
    Zimmer A; Hammer R
    Arzneimittelforschung; 1981; 31(1a):212-6. PubMed ID: 7195224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human pharmacokinetics of AR-L 115 BS (author's transl)].
    Roth W; Zimmer A; Busch U
    Arzneimittelforschung; 1981; 31(1a):236-9. PubMed ID: 7195229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in calcium sensitivity of cardiac myofibrils contributes to the cardiotonic action of sulmazole.
    van Meel JC; Zimmermann R; Diederen W; Erdman E; Mrwa U
    Biochem Pharmacol; 1988 Jan; 37(2):213-20. PubMed ID: 2829914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotropic "A" ring substituted sulmazole and isomazole analogues.
    Barraclough P; Black JW; Cambridge D; Collard D; Firmin D; Gerskowitch VP; Glen RC; Giles H; Hill AP; Hull RA
    J Med Chem; 1990 Aug; 33(8):2231-9. PubMed ID: 2165165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sulmazole and pimobendan on contractility of skinned fibres from frog skeletal muscle.
    Piazzesi G; Morano I; Rüegg JC
    Arzneimittelforschung; 1987 Oct; 37(10):1141-3. PubMed ID: 3435586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.
    Endoh M; Yanagisawa T; Morita T; Taira N
    J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioanalyses and pharmacokinetics of nafronyl in the dog.
    Garrett ER
    J Pharm Sci; 1984 May; 73(5):635-49. PubMed ID: 6737238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
    Endoh M; Yanagisawa T; Taira N; Blinks JR
    Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.